Tumor Necrosis Factor Receptor Superfamily, Member 1B (TNFRSF1B) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Tumor Necrosis Factor Receptor Superfamily, Member 1B (TNFRSF1B) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTumor Necrosis Factor Receptor Superfamily, Member 1B (TNFRSF1B)
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciesrat
Isotypen/a
Formataffinity purified
Size0.01 mg, 0.02 mg, 0.05 mg
Concentration200ug/ml
ApplicationsWestern Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a rabbit polyclonal antibody raised against TNFRSF1B. It has beenselected for its ability to recognize TNFRSF1B in immunohistochemical staining andwestern blotting.
ImmunogenImmunogen: Recombinant TNFRSF1B (Ala25~Met229) expressed in E Coli. Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2056015
Other Names[tumor necrosis factor receptor superfamily member 1B; Tumor necrosis factor receptor superfamily member 1B; tumor necrosis factor receptor superfamily member 1B; TNF receptor superfamily member 1B; Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; TNF-RII; TNFR-II; p75; p80 TNF-alpha receptor; CD_antigen: CD120b]
Gene, Accession #[TNFRSF1B], Gene ID: 156767, NCBI: NP_569110.1, UniProt: Q80WY6
Catalog #MBS2028294
Price$110, $130, $185
Order / More InfoTumor Necrosis Factor Receptor Superfamily, Member 1B (TNFRSF1B) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.